PLEASE DO BUSINESS WITH THOSE WHO DO BUSINESS WITH US -- OUR ADVERTISERS.

THANK YOU FOR VISITING OUR WEB PORTAL. PLEASE TELL A FRIEND.

YOU can speak out and be heard by having your own "Column" - Visit the "Public Opinion" Section above.

WE ACKNOWLEDGE AND THANK ALL OUR SOURCES FOR THEIR CONTRIBUTIONS IN MAKING US AMERICA'S NUMBER ONE NEWS INFORMATION PORTAL.

ATTENTION TALK SHOW HOSTS: We are honored that many radio talk show hosts use our Web Portal for their "show prep." We would appreciate your occasional mention of our site to your audience. Thanks!

ADVERTISEMENT: If you want to advertise your business or Web Site, send us an email by clicking on "Contact" above. It could be the best business decision you make.

ABC Online Canada National Post Daily Telegraph The Observer Wired News Xinhua News

VOA VIEW -- Is the opinion of "Voice of Americans", which is a private entity not affiliated in any way with the United States government or any of its agencies. The opinions expressed here, in whatever medium or format, are not necessarily the opinions of the ownership or advertisers of this web site - 0415.

     President Trump said that his administration has signed agreements with nine additional pharmaceutical firms to offer discounted drugs to state Medicaid programs.  A good move.

     "In total, these agreements are projected to save Americans more than $600 billion over a very short period of time," Mr. Trump said during an announcement at the Oval Office.  The announcement is part of Mr. Trump's "most-favored-nation" drug pricing policy, aimed at offering drugs in the U.S. at a comparable price to that in other developed nations. The effort involves selling discounted drugs directly to consumers on TrumpRx, a website the Trump administration launched in February, where Americans can get discounts on name-brand medications.

     Seventeen pharmaceutical companies have already agreed to voluntarily lower their drug prices as part of the "most favored nation" deal over the last year, according to the White House.  "With today's announcement, we now have 26 companies representing 90% of the domestic pharmaceutical market, and the other 10% are also coming in," Mr. Trump said. "They have no choice."

     The nine new firms that have agreed to offer consumer discounts are midsize pharmaceutical firms, according to a White House fact sheet. They include Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals and UCB. The White House said the companies will provide access to their drugs to every state Medicaid program in the U.S., "resulting in billions of dollars in savings for Americans."